3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Head & Neck
1
Breast
1
Conditions
Prostatic Neoplasms
2
Interventions
Docetaxel
229
Radiotherapy
206
Magnetic Resonance Spectroscopy
204
Radiosurgery
176
Gemcitabine
155
pembrolizumab
151
Nivolumab
147
enzalutamide
140
Prednisone
129
Cisplatin
123
Leuprolide
119
Androgen Antagonists
117
Abiraterone Acetate
114
Sunitinib
106
Specimen Handling
94
Surveys and Questionnaires
91
Goserelin
91
bicalutamide
90
Carboplatin
88
Ipilimumab
82
gallium 68 PSMA-11
80
Blood Specimen Collection
78
Everolimus
73
apalutamide
72
Radiation
71
Standard of Care
68
Biopsy
68
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
66
Paclitaxel
64
Cyclophosphamide
62
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
WW Domain-Containing Oxidoreductase
×
Genitourinary
×
Clear all
NCT04049747
2025-03-24
IP4-CHRONOS
Imperial College London
Phase NA
Completed
100 enrolled
23 charts
NCT04239599
2022-09-29
RCT-PHART2
Sunnybrook Health Sciences Centre
Phase NA
Unknown
178 enrolled